Corino Therapeutics

Focus: Corino Therapeutics is a biotech firm focused on acquisition and development of therapeutic candidates, headquartered in Charlottesville, NC. The company operates at an early stage with a minimal public footprint.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Corino Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Corino Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Tolcapone

Transthyretin Amyloidosis

Phase 1

Clinical Trials (1)

NCT03591757Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)

Phase 1

Help build intelligence for Corino Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage acquisition and development model offers direct exposure to drug repositioning and clinical advancement strategy
Tolcapone program in transthyretin amyloidosis targets a rare disease with unmet medical need and limited competition
Ground-floor opportunity at a focused biotech with potential for outsized equity upside at early stage

Watch Out For

Zero active job openings and minimal employee count signal either very early stage, dormant status, or recruitment freeze
Only 2 Phase 1 trials across entire pipeline with no Phase 2/3 programs indicate earliest-stage risk profile and multi-year timeline to clinical validation
Complete absence of published data, financial reporting, and public news creates transparency risk and difficulty assessing true operational status

Generated by Claude from Corino Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Tolcapone

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT03633591A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

Phase 1

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo